Amicus Therapeutics Battles Fabry Disease
Amicus Therapeutics is an advancing global biotechnology company with a passion for treating and finding cures for rare and orphan diseases. Orphan diseases are classified as those not widely present in our current population. Their current treatment lines help with a vast range of human genetic diseases, such as Fabry disease and Pompe disease.
Amicus Therapeutics headquarters are based in Cranbury, New Jersey where the company first went public in 2007 under the NASDAQ trading symbol FOLD (https://www.google.com/finance?cid=706165). Head members of the company are CEO John Francis Crowley, President Bradley L. Campbell, and Founder John Francis Crowley. The company was founded on February 4, 2002.
One of the goals of Amicus Therapeutics is to develop specialized platforms to develop specific treatments for human genetic diseases. Their aim is towards targeting specific mutated proteins. Scientists who are researching these methods are looking to find advanced treatments for those patients who suffer from these rare and debilitating diseases.
At Amicus Therapeutics, there is also the realization for the need for patient advocacy (YourBeautyCraze). Amicus Patient and Professional Advocacy collaborates with individual patients, their caregivers, health practitioners, and other patient organizations to find the best ways possible to help those in the rare disease community. This added support helps those afflicted with the disease to have a sense of empowerment and lessen the burden of the difficulties that their illnesses bring. By offering every resource and support possible, Amicus Therapeutics stands by their belief of healing beyond disease.
The Chairman and CEO of Amicus Therapeutics have often commented about how proud he is for the persistence that his team shows towards upholding the highest standards of safety and professionalism towards their patients. Their dedication to ethics and compliance are what help make the company work harder for the patients. To see a company where all share the same vision and passion towards the patients is something rare and special. All the best to those helping others in need.